Comparative efficacy and safety of 5-day cefaclor and 10-day amoxycillin treatment of group A streptococcal pharyngitis in children

Susanna Esposito, Paola Marchisio, Samantha Bosis, Roberta Droghetti, Roberto Mattina, Nicola Principi

Research output: Contribution to journalArticle

Abstract

A total of 384 children with group A β-haemolytic streptococcal (GABHS) pharyngitis were randomized to receive either 40 mg/kg/day of cefaclor in two doses for 5 days (192 patients), or 40 mg/kg/day of amoxycillin in three doses for 10 days (192 patients). The signs and symptoms of pharyngitis were recorded and throat cultures were obtained at presentation and on days 6-7, 11-15, 16-20 and 28-35. Patient compliance was significantly higher in the children treated with cefaclor (100 vs. 95.1%; P=0.003). At the end of follow-up, the percentage of clinical success was 91.4% for cefaclor and 91.9% for amoxycillin (P=0.974); bacteriological success was obtained in 85.7 and 89.6% children (P=0.348), respectively. Both treatments were well-tolerated with adverse event rates of 8.3% in the cefaclor group and 9.4% in the amoxcillin group (P=0.857). Our study shows that five days' treatment with cefaclor is as effective and safe as the conventional 10-day course of amoxycillin in the treatment of GABHS pharyngitis, but compliance seems to be significantly greater.

Original languageEnglish
Pages (from-to)28-33
Number of pages6
JournalInternational Journal of Antimicrobial Agents
Volume20
Issue number1
DOIs
Publication statusPublished - 2002

Fingerprint

Cefaclor
Pharyngitis
Amoxicillin
Safety
Therapeutics
Patient Compliance
Pharynx
Compliance
Signs and Symptoms

Keywords

  • Amoxycillin
  • Cefaclor
  • Children
  • Group A β-haemolytic Streptococcus
  • Pharyngitis
  • Short therapy

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Microbiology
  • Parasitology
  • Virology
  • Immunology and Allergy
  • Infectious Diseases

Cite this

Comparative efficacy and safety of 5-day cefaclor and 10-day amoxycillin treatment of group A streptococcal pharyngitis in children. / Esposito, Susanna; Marchisio, Paola; Bosis, Samantha; Droghetti, Roberta; Mattina, Roberto; Principi, Nicola.

In: International Journal of Antimicrobial Agents, Vol. 20, No. 1, 2002, p. 28-33.

Research output: Contribution to journalArticle

@article{1e888ae0874e462aa5fa9c9b3e9d63a7,
title = "Comparative efficacy and safety of 5-day cefaclor and 10-day amoxycillin treatment of group A streptococcal pharyngitis in children",
abstract = "A total of 384 children with group A β-haemolytic streptococcal (GABHS) pharyngitis were randomized to receive either 40 mg/kg/day of cefaclor in two doses for 5 days (192 patients), or 40 mg/kg/day of amoxycillin in three doses for 10 days (192 patients). The signs and symptoms of pharyngitis were recorded and throat cultures were obtained at presentation and on days 6-7, 11-15, 16-20 and 28-35. Patient compliance was significantly higher in the children treated with cefaclor (100 vs. 95.1{\%}; P=0.003). At the end of follow-up, the percentage of clinical success was 91.4{\%} for cefaclor and 91.9{\%} for amoxycillin (P=0.974); bacteriological success was obtained in 85.7 and 89.6{\%} children (P=0.348), respectively. Both treatments were well-tolerated with adverse event rates of 8.3{\%} in the cefaclor group and 9.4{\%} in the amoxcillin group (P=0.857). Our study shows that five days' treatment with cefaclor is as effective and safe as the conventional 10-day course of amoxycillin in the treatment of GABHS pharyngitis, but compliance seems to be significantly greater.",
keywords = "Amoxycillin, Cefaclor, Children, Group A β-haemolytic Streptococcus, Pharyngitis, Short therapy",
author = "Susanna Esposito and Paola Marchisio and Samantha Bosis and Roberta Droghetti and Roberto Mattina and Nicola Principi",
year = "2002",
doi = "10.1016/S0924-8579(02)00118-8",
language = "English",
volume = "20",
pages = "28--33",
journal = "International Journal of Antimicrobial Agents",
issn = "0924-8579",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Comparative efficacy and safety of 5-day cefaclor and 10-day amoxycillin treatment of group A streptococcal pharyngitis in children

AU - Esposito, Susanna

AU - Marchisio, Paola

AU - Bosis, Samantha

AU - Droghetti, Roberta

AU - Mattina, Roberto

AU - Principi, Nicola

PY - 2002

Y1 - 2002

N2 - A total of 384 children with group A β-haemolytic streptococcal (GABHS) pharyngitis were randomized to receive either 40 mg/kg/day of cefaclor in two doses for 5 days (192 patients), or 40 mg/kg/day of amoxycillin in three doses for 10 days (192 patients). The signs and symptoms of pharyngitis were recorded and throat cultures were obtained at presentation and on days 6-7, 11-15, 16-20 and 28-35. Patient compliance was significantly higher in the children treated with cefaclor (100 vs. 95.1%; P=0.003). At the end of follow-up, the percentage of clinical success was 91.4% for cefaclor and 91.9% for amoxycillin (P=0.974); bacteriological success was obtained in 85.7 and 89.6% children (P=0.348), respectively. Both treatments were well-tolerated with adverse event rates of 8.3% in the cefaclor group and 9.4% in the amoxcillin group (P=0.857). Our study shows that five days' treatment with cefaclor is as effective and safe as the conventional 10-day course of amoxycillin in the treatment of GABHS pharyngitis, but compliance seems to be significantly greater.

AB - A total of 384 children with group A β-haemolytic streptococcal (GABHS) pharyngitis were randomized to receive either 40 mg/kg/day of cefaclor in two doses for 5 days (192 patients), or 40 mg/kg/day of amoxycillin in three doses for 10 days (192 patients). The signs and symptoms of pharyngitis were recorded and throat cultures were obtained at presentation and on days 6-7, 11-15, 16-20 and 28-35. Patient compliance was significantly higher in the children treated with cefaclor (100 vs. 95.1%; P=0.003). At the end of follow-up, the percentage of clinical success was 91.4% for cefaclor and 91.9% for amoxycillin (P=0.974); bacteriological success was obtained in 85.7 and 89.6% children (P=0.348), respectively. Both treatments were well-tolerated with adverse event rates of 8.3% in the cefaclor group and 9.4% in the amoxcillin group (P=0.857). Our study shows that five days' treatment with cefaclor is as effective and safe as the conventional 10-day course of amoxycillin in the treatment of GABHS pharyngitis, but compliance seems to be significantly greater.

KW - Amoxycillin

KW - Cefaclor

KW - Children

KW - Group A β-haemolytic Streptococcus

KW - Pharyngitis

KW - Short therapy

UR - http://www.scopus.com/inward/record.url?scp=0035996895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035996895&partnerID=8YFLogxK

U2 - 10.1016/S0924-8579(02)00118-8

DO - 10.1016/S0924-8579(02)00118-8

M3 - Article

C2 - 12127708

AN - SCOPUS:0035996895

VL - 20

SP - 28

EP - 33

JO - International Journal of Antimicrobial Agents

JF - International Journal of Antimicrobial Agents

SN - 0924-8579

IS - 1

ER -